Section 16

Section 16 Substance Use Disorder Trust Fund

Section 2YYYY of said chapter 29 of the General Laws, as amended by section 5 of chapter 31 of the acts of 2020, is hereby further amended by striking out the second paragraph and inserting in place thereof the following paragraph:-

The secretary may expend, without further appropriation: (i) not more than $27,000,000 per year in fiscal year 2020 and not more than $53,000,000 in fiscal year 2021 and not more than $60,000,000 in fiscal year 2022 from the fund to expand and support the residential treatment system to treat individuals with a substance use disorder or co-occurring mental health and substance use disorder; (ii) not more than $11,000,000 per year in fiscal year 2020 and not more than $32,000,000 in fiscal year 2021 and not more than $40,000,000 in fiscal year 2022 from the fund to expand and support access to medication assisted treatment; (iii) not more than $8,000,000 per year in fiscal year 2020 and not more than $15,000,000 per year in fiscal years 2021 and 2022 from the fund to expand and support access to recovery treatment support services; and (iv) not more than $4,000,000 per year in fiscal year 2020 and not more than $10,000,000 in fiscal year 2021 and not more than $15,000,000 in fiscal year 2022 from the fund to implement and support American Society of Addiction Medicine assessment and care planning across substance use treatment providers. For the purpose of accommodating timing discrepancies between the receipt of revenues and related expenditures, the fund may incur expenses, and the comptroller shall certify for payment, amounts not to exceed the most recent revenue estimate as certified by the MassHealth director, as reported in the state accounting system. Amounts credited to the fund shall not be subject to further appropriation and monies remaining in the fund at the end of a fiscal year shall not revert to the General Fund and shall be available for expenditure in the subsequent fiscal year.

Summary

This section amends the Substance Use Disorder Trust Fund to adjust anticipated expenditures for FY22.